| For: | Thomas RM, Ruel E, Shantavasinkul PC, Corsino L. Endocrine hypertension: An overview on the current etiopathogenesis and management options. World J Hypertens 2015; 5(2): 14-27 [PMID: 26413481 DOI: 10.5494/wjh.v5.i2.14] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3168/full/v5/i2/14.htm |
| Number | Citing Articles |
| 1 |
Syeda Neha Fatima, Fatima Umaira Saeed, Mariya Sana. Hypertension Unraveled: From Mechanisms to Modern Management. International Journal of Innovative Science and Research Technology 2025; doi: 10.38124/ijisrt/25sep335
|
| 2 |
V. O. Shuper, S. V. Shuper, I. V. Trefanenko, H. I. Shumko, T. V. Reva . Pharmacotherapeutic Features of the Management of Patients with Secondary Arterial Hypertension of Endocrine Genesis. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2022; 7(4) doi: 10.26693/jmbs07.04.122
|
| 3 |
Filippo Ceccato, Marco Boscaro. Cushing’s Syndrome: Screening and Diagnosis. High Blood Pressure & Cardiovascular Prevention 2016; 23(3) doi: 10.1007/s40292-016-0153-4
|
| 4 |
I. A. Vaychulis, I. I. Shaposhnik. The Main Provisions of the International Recommendations on Detection of Endocrine Hypertension. Kardiologiia 2019; 59(10) doi: 10.18087/cardio.2019.10.2669
|
| 5 |
William G. La Cava, Paul C. Lee, Imran Ajmal, Xiruo Ding, Priyanka Solanki, Jordana B. Cohen, Jason H. Moore, Daniel S. Herman. A flexible symbolic regression method for constructing interpretable clinical prediction models. npj Digital Medicine 2023; 6(1) doi: 10.1038/s41746-023-00833-8
|
| 6 |
Iuri Martin Goemann, Ana Luiza Maia. Endocrine Hypertension. 2023; doi: 10.1016/B978-0-323-96120-2.00003-0
|
| 7 |
Agata Buonacera, Benedetta Stancanelli, Lorenzo Malatino. Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications. High Blood Pressure & Cardiovascular Prevention 2017; 24(3) doi: 10.1007/s40292-017-0200-9
|
| 8 |
Ning Xiao, Yi Ding, Bing Cui, Rong-rong Li, Xin-ru Qu, Hong Zhou, Ka-hei Au, Xiu-de Fan, Jin-chen Xie, Yuan Huang, Shu-min Zhang, Hong-yi Du, Yi-fan Wu, Peng Wang, Xiao-fei Hu, You-fa Wang, Jia-jun Zhao, Wah Yang, Ying Wang, Xiao-lei Zhang, Wei Chen, Yao-hua Zhang, Sheng-shou Hu, Yu-fang Bi, Xue Feng. Navigating obesity: A comprehensive review of epidemiology, pathophysiology, complications and management strategies. The Innovation Medicine 2024; 2(3) doi: 10.59717/j.xinn-med.2024.100090
|
| 9 |
Natividad Pons Fernández, Francisca Moreno, Julia Morata, Ana Moriano, Sara León, Carmen De Mingo, Ángel Zuñiga, Fernando Calvo. Familial hyperaldosteronism type III a novel case and review of literature. Reviews in Endocrine and Metabolic Disorders 2019; 20(1) doi: 10.1007/s11154-018-9481-0
|
| 10 |
Sachin Modi, Santosha Mantha, Amit S. Nachankar, Ankur Rai, Shilika Lalwani, Vandana Rana, Vikram Singh Shekhawat. Unveiling multiple endocrine neoplasia type 2A through cutaneous lichen amyloidosis: A rare clinical association. IJEM Case Reports 2026; 4(1) doi: 10.4103/ijemcr.ijemcr_47_25
|
| 11 |
Irina Benenson, Frederick Waldron, Molly Bradshaw, Tracy Vitale. Endocrine Hypertension: A Primer for Primary Care Nurse Practitioners. The Journal for Nurse Practitioners 2019; 15(10) doi: 10.1016/j.nurpra.2019.08.028
|
| 12 |
Manuel Morales-Ruiz, María Rodríguez-García, Nerea Sainz-Pastor, Alex Barragán-Muñoz, Gregori Casals. Primary Aldosteronism: Physiopathology and Diagnosis. Vitamins and Hormones 2026; 130 doi: 10.1016/bs.vh.2025.08.005
|
| 13 |
Bogdan-Sorin Tudurachi, Laura Țăpoi, Delia Lidia Şalaru, Laura Cătălina Benchea, Carmen Elena Pleșoianu, Radu Andy Sascău, Cristian Stǎtescu. Endocrine Hypertension – a Multifaceted Disease. Romanian Journal of Cardiology 2022; 32(2) doi: 10.2478/rjc-2022-0017
|
| 14 |
Mohammed Azfar Siddiqui, Irfan Amir Kazi, Frank H Miller, Pardeep K Mittal, Esra Demirtas, Khaled M Elsayes, Ayman Nada. Endocrine hypertension: the role of imaging in diagnosis and management. British Journal of Radiology 2026; 99(1180) doi: 10.1093/bjr/tqag028
|
| 15 |
Mohammed Azfar Siddiqui, Pardeep K. Mittal, Brent P. Little, Frank H. Miller, Ece Isin Akduman, Kamran Ali, Sara Sartaj, Courtney C. Moreno. Secondary Hypertension and Complications: Diagnosis and Role of Imaging. RadioGraphics 2019; 39(4) doi: 10.1148/rg.2019180184
|
| 16 |
Aleksandra Huljić, Aleksandra Caričić, Bojan Pavković, Marija Zarić, Bojan Prokić, Milica Kuljanin. Pheochromocytoma as a cause of secondary arterial hypertension. Timocki medicinski glasnik 2018; 43(1) doi: 10.5937/tmg1801022H
|
| 17 |
Wei Wang, Feng Wei, RanHao Li, JiaHui Tian. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma. Medicine 2019; 98(43) doi: 10.1097/MD.0000000000017418
|
| 18 |
Francisco Bandeira, Morgana Barbosa Duarte, Ana Maíra Quental da Nóbrega. Endocrinology and Diabetes. 2022; doi: 10.1007/978-3-030-90684-9_11
|
| 19 |
Sai Sudha Mannemuddhu, Ian Macumber, Joshua A. Samuels, Joseph T. Flynn, Andrew M. South. When Hypertension Grows Up: Implications for Transitioning Care of Adolescents and Young Adults With Hypertension From Pediatric to Adult Health Care Providers. Advances in Chronic Kidney Disease 2022; 29(3) doi: 10.1053/j.ackd.2021.11.005
|
| 20 |
I Bombil, RA Muganza, R Netshamutsindo. Experience of a tertiary/quaternary unit with surgery for endocrine hypertension. South African Journal of Surgery 2024; 62(4) doi: 10.36303/SAJS.00168
|
| 21 |
María del Mar Rodríguez Rodríguez, Lucía Jiménez Mendiguchía, Marta Rosillo Coronado, Ana García Cano. Diagnóstico diferencial del hiperaldosteronismo primario. Revista del Laboratorio Clínico 2017; 10(3) doi: 10.1016/j.labcli.2017.02.002
|
| 22 |
Joseph M. Pappachan, Harit N. Buch. Hypertension: from basic research to clinical practice. Advances in Experimental Medicine and Biology 2016; 956 doi: 10.1007/5584_2016_26
|
| 23 |
Stanley M. Chen Cardenas, Prasanna Santhanam. 11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature. Endocrine 2020; 70(3) doi: 10.1007/s12020-020-02474-3
|
| 24 |
Jia-Yuh Sheu, Shuo-Meng Wang, Vin-Cent Wu, Kuo-How Huang, Chi-Shin Tseng, Yuan-Ju Lee, Yao-Chou Tsai, Yen-Hung Lin, Jeff S. Chueh. Estimated glomerular filtration rate-dip after medical target therapy associated with increased mortality and cardiovascular events in patients with primary aldosteronism. Journal of Hypertension 2023; 41(9) doi: 10.1097/HJH.0000000000003479
|
| 25 |
Jeongmin Lee, Jeonghoon Ha, Sang-Kuon Lee, Hye Lim Park, Sung-Hoon Kim, Dong-Jun Lim, Jung Min Lee, Sang-Ah Chang, Moo Il Kang, Min-Hee Kim. Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series. International Journal of General Medicine 2021; doi: 10.2147/IJGM.S288774
|
| 26 |
Ilkay Cakir, Serkan Senol, Yasin Simsek, Zuleyha Karaca, Kursad Unluhizarci, Fatih Tanrıverdi. Primary hyperaldosteronism presenting with rhabdomyolysis in emergency room – Case report. Journal of Acute Disease 2016; 5(3) doi: 10.1016/j.joad.2016.03.020
|
| 27 |
Tarun Saxena, Azeema Ozefa Ali, Manjari Saxena. Pathophysiology of essential hypertension: an update. Expert Review of Cardiovascular Therapy 2018; 16(12) doi: 10.1080/14779072.2018.1540301
|
| 28 |
Eleni P. Kotanidou, Styliani Giza, Vasiliki-Regina Tsinopoulou, Maria Vogiatzi, Assimina Galli-Tsinopoulou. Diagnosis and Management of Endocrine Hypertension in Children and Adolescents. Current Pharmaceutical Design 2020; 26(43) doi: 10.2174/1381612826666201113103614
|
| 29 |
Ernest E. Lack, Edina Paal. Urologic Surgical Pathology. 2020; doi: 10.1016/B978-0-323-54941-7.00016-5
|
| 30 |
Anand Kumar Mishra, Kulranjan Singh, Pooja Ramakant, Amit Agarwal. Evidence-Based Endocrine Surgery. 2018; doi: 10.1007/978-981-10-1124-5_28
|